These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

709 related items for PubMed ID: 19172123

  • 1. Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease.
    Joishy M, Davies I, Ahmed M, Wassel J, Davies K, Sayers A, Jenkins H.
    J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):48-54. PubMed ID: 19172123
    [Abstract] [Full Text] [Related]

  • 2. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ.
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy.
    von Roon AC, Karamountzos L, Purkayastha S, Reese GE, Darzi AW, Teare JP, Paraskeva P, Tekkis PP.
    Am J Gastroenterol; 2007 Apr; 102(4):803-13. PubMed ID: 17324124
    [Abstract] [Full Text] [Related]

  • 4. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease.
    Fagerberg UL, Lööf L, Lindholm J, Hansson LO, Finkel Y.
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):414-20. PubMed ID: 18030206
    [Abstract] [Full Text] [Related]

  • 5. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
    Kolho KL, Raivio T, Lindahl H, Savilahti E.
    Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
    [Abstract] [Full Text] [Related]

  • 6. Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease.
    Walker TR, Land ML, Kartashov A, Saslowsky TM, Lyerly DM, Boone JH, Rufo PA.
    J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):414-22. PubMed ID: 17414136
    [Abstract] [Full Text] [Related]

  • 7. Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease.
    Reinders CA, Jonkers D, Janson EA, Stockbrügger RW, Stobberingh EE, Hellström PM, Lundberg JO.
    Scand J Gastroenterol; 2007 Oct; 42(10):1151-7. PubMed ID: 17852876
    [Abstract] [Full Text] [Related]

  • 8. Accuracy of four fecal assays in the diagnosis of colitis.
    Schoepfer AM, Trummler M, Seeholzer P, Criblez DH, Seibold F.
    Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964
    [Abstract] [Full Text] [Related]

  • 9. Review of fecal biomarkers in inflammatory bowel disease.
    Sutherland AD, Gearry RB, Frizelle FA.
    Dis Colon Rectum; 2008 Aug; 51(8):1283-91. PubMed ID: 18543035
    [Abstract] [Full Text] [Related]

  • 10. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
    Silberer H, Küppers B, Mickisch O, Baniewicz W, Drescher M, Traber L, Kempf A, Schmidt-Gayk H.
    Clin Lab; 2005 Aug; 51(3-4):117-26. PubMed ID: 15819166
    [Abstract] [Full Text] [Related]

  • 11. Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease.
    Lamb CA, Mohiuddin MK, Gicquel J, Neely D, Bergin FG, Hanson JM, Mansfield JC.
    Br J Surg; 2009 Jun; 96(6):663-74. PubMed ID: 19384912
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice.
    Berni Canani R, Rapacciuolo L, Romano MT, Tanturri de Horatio L, Terrin G, Manguso F, Cirillo P, Paparo F, Troncone R.
    Dig Liver Dis; 2004 Jul; 36(7):467-70. PubMed ID: 15285526
    [Abstract] [Full Text] [Related]

  • 13. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.
    Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, Camilleri M, Hanauer SB.
    Am J Gastroenterol; 2003 Jun; 98(6):1309-14. PubMed ID: 12818275
    [Abstract] [Full Text] [Related]

  • 14. [Fecal calprotectin: a diagnostic tool for inflammatory bowel disease].
    Fraga M, Godat S, Nydegger A, Moradpour D, Schoepfer AM.
    Rev Med Suisse; 2012 Sep 05; 8(352):1669-70, 1672-3. PubMed ID: 22988727
    [Abstract] [Full Text] [Related]

  • 15. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R.
    Dig Liver Dis; 2008 Jul 05; 40(7):547-53. PubMed ID: 18358796
    [Abstract] [Full Text] [Related]

  • 16. [Assessment of fecal calprotectin concentration as inflammatory marker in inflammatory bowel diseases in children--preliminary report].
    Krzesiek E, Iwańczak B.
    Pol Merkur Lekarski; 2010 Oct 05; 29(172):241-6. PubMed ID: 21207640
    [Abstract] [Full Text] [Related]

  • 17. Relationship between fecal lactoferrin and inflammatory bowel disease.
    Dai J, Liu WZ, Zhao YP, Hu YB, Ge ZZ.
    Scand J Gastroenterol; 2007 Dec 05; 42(12):1440-4. PubMed ID: 17852860
    [Abstract] [Full Text] [Related]

  • 18. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin.
    Schröder O, Naumann M, Shastri Y, Povse N, Stein J.
    Aliment Pharmacol Ther; 2007 Oct 01; 26(7):1035-42. PubMed ID: 17877510
    [Abstract] [Full Text] [Related]

  • 19. [Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease].
    van den Bergh FA, Kolkman JJ, Russel MG, Vlaskamp RT, Vermes I.
    Ned Tijdschr Geneeskd; 2003 Nov 29; 147(48):2360-5. PubMed ID: 14677476
    [Abstract] [Full Text] [Related]

  • 20. Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease.
    Lundberg JO, Hellström PM, Fagerhol MK, Weitzberg E, Roseth AG.
    Nat Clin Pract Gastroenterol Hepatol; 2005 Feb 29; 2(2):96-102. PubMed ID: 16265127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.